Cargando…
COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
Autores principales: | Ryan, Paul MacDaragh, Caplice, Noel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298719/ https://www.ncbi.nlm.nih.gov/pubmed/32532804 http://dx.doi.org/10.1136/openhrt-2020-001302 |
Ejemplares similares
-
COVID-19—Where Have All the STEMIs Gone?
por: Tanner, Richard, et al.
Publicado: (2020) -
Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
por: Sommerstein, Rami, et al.
Publicado: (2020) -
Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Guo, Junyi, et al.
Publicado: (2020) -
Inside the skin of a patient with diabetes: fostering cognitive empathy through insulin pump simulation
por: Ryan, Paul MacDaragh
Publicado: (2021) -
Management of COVID-19-associated multisystem inflammatory syndrome in children: A comprehensive literature review
por: Kiss, Andreea, et al.
Publicado: (2021)